Antimicrobial susceptibility among gram-positive and gram-negative blood-borne pathogens collected between 2012-2016 as part of the Tigecycline Evaluation and Surveillance Trial

Table 5 Occurrence of every regions with low susceptibility to antibiotics in major blood-borne pathogens (%)

bacterial	number of antibiotics^a × 2	Africa	Asia	Europe	North America	Latin America
E. coli	14	7 (50.0)	4 (28.6)	0 (0.0)	0 (0.0)	3 (14.3)
K .pneumoniae	16	8 (50.0)	0 (0.0)	3 (18.8)	0 (0.0)	5 (31.3)
S. marcescens	6	2 (33.1)	1 (16.7)	0 (0.0)	2 (33.3)	1 (16.7)
E. cloacae	16	5 (31.3)	6 (37.5)	2 (12.5)	0 (0.0)	3 (18.8)
P. aeruginosa	10	1 (10.0)	3 (30.0)	4 (40.0)	0 (0.0)	2 (20.0)
A. baumannii	16	7 (43.8)	1 (6.3)	1 (6.3)	0 (0.0)	7 (43.8)
S. aureus	4	2 (50.0)	2 (50.0)	0 (0.0)	0 (0.0)	0 (0.0)
E. faecalis	4	2 (50.0)	0 (25.0)	1 (25.0)	1 (25.0)	0 (0.0)
E. faecium	11^b	2^b(18.2)	2 (18.2)	2^b(18.2)	2 (18.2)	3 (27.3)
S. pneumoniae	14	2 (14.3)	7 (50.0)	0 (0.0)	2 (14.3)	3 (21.4)
Total	111	38 (34.2)	26 (23.4)	13 (11.7)	7 (6.3)	27 (24.3)

ISSN: 2047-2994